Monday, April 08, 2024 10:56:14 PM
https://www.dailymail.co.uk/health/article-13284461/pancreatic-cancer-breakthrough-deadliest-disease-study.html
Recent RVMD News
- Revolution Medicines to Report Financial Results for First Quarter 2024 After Market Close on May 8, 2024 • GlobeNewswire Inc. • 05/01/2024 08:05:56 PM
- Revolution Medicines Announces Publication on the Discovery of and Translational Research for RMC-6236, an Investigational RAS(ON) Multi-Selective Tri-Complex Inhibitor Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins • GlobeNewswire Inc. • 04/09/2024 07:34:07 PM
- Revolution Medicines Announces Publications on the Discovery and Preclinical Profile of Representative of a New Class of RAS(ON) Multi-Selective Inhibitors Designed to Block Full Spectrum of Oncogenic RAS(ON) Proteins • GlobeNewswire Inc. • 04/08/2024 03:36:55 PM
- Revolution Medicines to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 04/04/2024 08:05:04 PM
- Revolution Medicines to Deliver Multiple Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2024 • GlobeNewswire Inc. • 03/28/2024 08:05:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:54:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:53:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/05/2024 09:52:43 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/04/2024 10:23:49 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2024 10:04:49 PM
- Revolution Medicines Reports Fourth Quarter and Full Year 2023 Financial Results and Update on Corporate Progress • GlobeNewswire Inc. • 02/26/2024 09:05:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/26/2024 09:04:06 PM
- Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2023 After Market Close on February 26, 2024 • GlobeNewswire Inc. • 02/20/2024 09:05:47 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/09/2024 10:22:05 PM
- Revolution Medicines to Participate in Upcoming Investor Conferences • GlobeNewswire Inc. • 02/01/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/24/2024 09:12:33 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/22/2024 09:18:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/09/2024 07:15:37 PM
- Revolution Medicines to Present at 42nd Annual J.P. Morgan Healthcare Conference • GlobeNewswire Inc. • 01/04/2024 12:00:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:10:14 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/20/2023 10:08:04 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/14/2023 11:22:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/14/2023 10:48:15 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 11/20/2023 11:24:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 11/20/2023 09:14:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM